New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 4, 2012
07:03 EDTCTICCell Therapeutics announced convertible preferred stock offering
Cell Therapeutics announced that it intends to offer and sell, subject to market and other conditions, 40,000 shares of its Series 17 Preferred Stock in an underwritten public offering. Each share of Series 17 Preferred Stock will have a stated value of $1,000 per share and will be convertible at the option of the holder, at any time after issuance, into shares of common stock prior to the automatic conversion of such shares in certain circumstances.
News For CTIC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 17, 2015
12:38 EDTCTICCTI BioPharma management to meet with Piper Jaffray
Subscribe for More Information
March 16, 2015
09:15 EDTCTICCTI BioPharma shares should be bought on weakness, says Roth Capital
Subscribe for More Information
05:27 EDTCTICCTI BioPharma announces publication of Phase 2 pacritinib study results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use